
Ternary Therapeutics is a UK drug discovery startup developing AI-designed molecular glue degraders for immunological and neuroinflammatory disorders, with laboratory operations at Stevenage Bioscience Catalyst.
The Crick at Regent's Place, 20 Triton Street, Office E, Level 2, London, Greater London, NW1 3BF, United Kingdom
View on map